Modulating the histamine H4 receptor enhances anti-tumor efficacy in a mouse model of breast cancer - Top-Institutions - MDSpire

Modulating the histamine H4 receptor enhances anti-tumor efficacy in a mouse model of breast cancer

  • By

  • Ramiro Vázquez

  • Paula Saibene

  • Maria Emilia Boix

  • Mariano Maio

  • Gabriela Salamone

  • Luciana Balboa

  • Mónica Vermeulen

  • April 21, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Breast Cancer Research
    • Tumor Immunology
    • Translational Oncology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Breast Cancer
    • Cancer Immunotherapy
    • Molecular Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Breast Cancer
    • Immuno-Oncology
    • Cancer Biology

  • #4

    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

    Baltimore, MD

    Key Differentiators

    • Breast Cancer
    • Tumor Immunology
    • Molecular Pharmacology

Original Source(s)

Modulating the histamine H4 receptor enhances anti-tumor efficacy in a mouse model of breast cancer

  • by Ramiro Vázquez, Paula Saibene, Maria Emilia Boix, Mariano Maio, Gabriela Salamone, Luciana Balboa, Mónica Vermeulen

  • April 21, 2026

Related Content

Recent advances in dissolving microneedles for breast cancer immunotherapy: local delivery and tumor microenvironment remodeling

HiGATE: hierarchical graph attention for multi-scale tissue encoder in computational pathology

Roswell Park at ASCO 2026: GLP-1s and Aggressive Breast Cancer, CAR T in Older Adults, AI-Informed Benchmarking

The research findings of experts from Roswell Park Comprehensive Cancer Center will be featured during the American Society of Clinical Oncology (ASCO) annual meeting May 29 to June 2 at McCormick Place in Chicago

  • May 25, 2026

  • 9 min